MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer

Clinical trial NCT03767335 · COMPLETED

Trial details

NCT number: NCT03767335
Sponsor: Menarini Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced or Metastatic Breast Cancer

Start date: 2018-11-13
Primary completion: 2024-02-23
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.